Clinical Trial Update: Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating topiramate for levodopa-induced dyskinesia in Parkinson's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Parkinson's Disease | Phase 2 | Status: TERMINATED